Abstract
Macrophages are essential regulators of inflammation and bone loss. Receptor activator of nuclear factor-κβ ligand (RANKL), a pro-inflammatory cytokine, is responsible for macrophage differentiation to osteoclasts and bone loss. We recently showed that 14-3-3ζ-knockout (YwhazKO) rats exhibit increased bone loss in the inflammatory arthritis model. 14-3-3ζ is a cytosolic adaptor protein that actively participates in many signaling transductions. However, the role of 14-3-3ζ in RANKL signaling or bone remodeling is unknown. We investigated how 14-3-3ζ affects osteoclast activity by evaluating its role in RANKL signaling. We utilized 14-3-3ζ-deficient primary bone marrow–derived macrophages obtained from wildtype and YwhazKO animals and RAW264.7 cells generated using CRISPR-Cas9. Our results showed that 14-3-3ζ-deficient macrophages, upon RANKL stimulation, have bigger and stronger tartrate-resistant acid phosphatase–positive multinucleated cells and increased bone resorption activity. The presence of 14-3-3ζ suppressed RANKL-induced MAPK and AKT phosphorylation, transcription factors (NFATC1 and p65) nuclear translocation, and subsequently, gene induction (Rank, Acp5, and Ctsk). Mechanistically, 14-3-3ζ interacts with TRAF6, an essential component of the RANKL receptor complex. Upon RANKL stimulation, 14-3-3ζ–TRAF6 interaction was increased, while RANK–TRAF6 interaction was decreased. Importantly, 14-3-3ζ supported TRAF6 ubiquitination and degradation by the proteasomal pathway, thus dampening the downstream RANKL signaling. Together, we show that 14-3-3ζ regulates TRAF6 levels to suppress inflammatory RANKL signaling and osteoclast activity. To the best of our knowledge, this is the first report on 14-3-3ζ regulation of RANKL signaling and osteoclast activation.
Document Type
Article
Publication Date
7-2024
Digital Object Identifier (DOI)
10.1016/j.jbc.2024.107487
Funding Information
American Association of Immunologists Ohio Department of Health National Society of Medical Research NIH-AI165521, NIH-AI155545, NIH-AI184880 National Institutes of Health (NIH) AI155545, AI165521
Repository Citation
Ayyasamy, R.; Fan, S.; Czernik, P.; Lecka-Czernik, B.; Chattopadhyay, S.; and Chakravarti, R., "14-3-3ζ suppresses RANKL signaling by destabilizing TRAF6" (2024). Markey Cancer Center Faculty Publications. 178.
https://uknowledge.uky.edu/markey_facpub/178
Notes/Citation Information
http://creativecommons.org/licenses/by/4.0